Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels

BACKGROUND: Metastatic adenocarcinomas of foregut origin are aggressive and have limited treatment options, poor quality of life, and a dismal prognosis. A subset of such patients with limited metastatic disease might have favorable outcomes with locoregional metastasis-directed therapies. This stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhiman, Ankit, Vining, Charles C., Witmer, Hunter D. D., Sood, Divya, Shergill, Ardaman, Kindler, Hedy, Roggin, Kevin K., Posner, Mitchell C., Ahmed, Osmanuddin S., Liauw, Stanley, Pitroda, Sean, Liao, Chih-Yi, Karrison, Theodore, Weichselbaum, Ralph, Polite, Blase, Eng, Oliver S., Catenacci, Daniel V. T., Turaga, Kiran K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Gastrointestinal Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730296/
https://www.ncbi.nlm.nih.gov/pubmed/34988836
http://dx.doi.org/10.1245/s10434-021-11249-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730296/
https://www.ncbi.nlm.nih.gov/pubmed/34988836
http://dx.doi.org/10.1245/s10434-021-11249-7

Ejemplares similares